Clinical trials
Phase 3 Coronavirus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 77 |
| 2021 | 26 |
| 2022 | 9 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
| Terminated | 20 |
| Unknown status | 19 |
| Recruiting | 7 |
| Withdrawn | 7 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| BioNTech SE | 7 |
| ModernaTX, Inc. | 5 |
| Novavax | 4 |
| CureVac | 3 |
| Azienda Ospedaliera Universitaria Integrata Verona | 2 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 2 |
| Eli Lilly and Company | 2 |
| Northwell Health | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 122 |
| COVID-19 | 102 |
| Severe Acute Respiratory Syndrome | 28 |
| Virus Diseases | 24 |
| Coronaviridae Infections | 16 |
| RNA Virus Infections | 16 |
| Nidovirales Infections | 14 |
| Pneumonia | 11 |
| Respiratory Distress Syndrome | 9 |
| Pneumonia, Viral | 8 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.